Global Pre-Implantation Genetic Diagnosis (PGD) Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Pre-Implantation Genetic Diagnosis (PGD) will have significant change from previous year. By the most conservative estimates of global Pre-Implantation Genetic Diagnosis (PGD) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Pre-Implantation Genetic Diagnosis (PGD) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Implantation Genetic Diagnosis (PGD) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Pre-Implantation Genetic Diagnosis (PGD), covering the supply chain analysis, impact assessment to the Pre-Implantation Genetic Diagnosis (PGD) market size growth rate in several scenarios, and the measures to be undertaken by Pre-Implantation Genetic Diagnosis (PGD) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
IGENOMIX
Genea Limited
Illumina, Inc.
Natera, Inc.
Quest Diagnostics
California Pacific Medical Center (CPMC)
Cooper Medical, Inc.
Thermo Fisher Scientific Inc.
LabCorp
Reproductive Genetic Innovations
CombiMatrix
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pre-Implantation Genetic Diagnosis (PGD) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pre-Implantation Genetic Diagnosis (PGD) market by identifying its various subsegments.
Focuses on the key global Pre-Implantation Genetic Diagnosis (PGD) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pre-Implantation Genetic Diagnosis (PGD) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pre-Implantation Genetic Diagnosis (PGD) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Pre-Implantation Genetic Diagnosis (PGD)?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Pre-Implantation Genetic Diagnosis (PGD) Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size 2015-2025
2.1.2 Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Region
2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
2.2.1 Chromosomal Abnormalities
2.2.2 Chromosomal Abnormalities
2.2.3 Freeze Embryo Testing
2.2.4 Aneuploidy Screening
2.2.5 HLA
2.2.6 Others
2.3 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
2.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
2.3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (2015-2020)
2.4 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
2.4.1 Stem Cell Therapy
2.4.2 IVF Prognosis
2.4.3 Late-Onset Genetic Disorders
2.4.4 Inherited Genetic Disease
2.4.5 Others
2.5 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
2.5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
2.5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application (2015-2020)
3 Global Pre-Implantation Genetic Diagnosis (PGD) by Players
3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Players
3.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Players (2018-2020)
3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Players (2018-2020)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pre-Implantation Genetic Diagnosis (PGD) by Regions
4.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions
4.2 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth
4.3 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth
4.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth
4.5 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth
5 Americas
5.1 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Countries
5.2 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
5.3 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions
6.2 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
6.3 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) by Countries
8.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
8.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast
10.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast (2021-2025)
10.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Regions
10.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type
10.8 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Application
11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 IGENOMIX
11.2.1 Company Details
11.2.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.2.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 IGENOMIX News
11.3 Genea Limited
11.3.1 Company Details
11.3.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.3.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Genea Limited News
11.4 Illumina, Inc.
11.4.1 Company Details
11.4.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Illumina, Inc. News
11.5 Natera, Inc.
11.5.1 Company Details
11.5.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Natera, Inc. News
11.6 Quest Diagnostics
11.6.1 Company Details
11.6.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.6.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Quest Diagnostics News
11.7 California Pacific Medical Center (CPMC)
11.7.1 Company Details
11.7.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.7.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 California Pacific Medical Center (CPMC) News
11.8 Cooper Medical, Inc.
11.8.1 Company Details
11.8.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.8.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Cooper Medical, Inc. News
11.9 Thermo Fisher Scientific Inc.
11.9.1 Company Details
11.9.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Thermo Fisher Scientific Inc. News
11.10 LabCorp
11.10.1 Company Details
11.10.2 Pre-Implantation Genetic Diagnosis (PGD) Product Offered
11.10.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 LabCorp News
11.11 Reproductive Genetic Innovations
11.12 CombiMatrix
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Pre-Implantation Genetic Diagnosis (PGD) Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Pre-Implantation Genetic Diagnosis (PGD) Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Chromosomal Abnormalities
Table 7. Major Players of X-linked Diseases
Table 8. Major Players of Freeze Embryo Testing
Table 9. Major Players of Aneuploidy Screening
Table 10. Major Players of HLA
Table 11. Major Players of Others
Table 12. Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Table 14. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
Table 16. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2018-2020)
Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
Table 19. Pre-Implantation Genetic Diagnosis (PGD) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Regions 2015-2020
Table 24. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries (2015-2020)
Table 26. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Table 28. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
Table 30. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2015-2020)
Table 32. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Table 34. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
Table 36. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries (2015-2020)
Table 38. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Table 40. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Pre-Implantation Genetic Diagnosis (PGD)
Table 49. Key Application and Potential Industries of Pre-Implantation Genetic Diagnosis (PGD)
Table 50. Key Challenges of Pre-Implantation Genetic Diagnosis (PGD)
Table 51. Key Trends of Pre-Implantation Genetic Diagnosis (PGD)
Table 52. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Regions
Table 54. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Application (2021-2025)
Table 58. Roche Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 59. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 60. Roche Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 61. Roche Main Business
Table 62. Roche Latest Developments
Table 63. IGENOMIX Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 64. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 65. IGENOMIX Main Business
Table 66. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 67. IGENOMIX Latest Developments
Table 68. Genea Limited Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 69. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 70. Genea Limited Main Business
Table 71. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 72. Genea Limited Latest Developments
Table 73. Illumina, Inc. Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 74. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 75. Illumina, Inc. Main Business
Table 76. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 77. Illumina, Inc. Latest Developments
Table 78. Natera, Inc. Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 79. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 80. Natera, Inc. Main Business
Table 81. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 82. Natera, Inc. Latest Developments
Table 83. Quest Diagnostics Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 84. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 85. Quest Diagnostics Main Business
Table 86. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 87. Quest Diagnostics Latest Developments
Table 88. California Pacific Medical Center (CPMC) Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 89. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 90. California Pacific Medical Center (CPMC) Main Business
Table 91. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 92. California Pacific Medical Center (CPMC) Latest Developments
Table 93. Cooper Medical, Inc. Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 94. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 95. Cooper Medical, Inc. Main Business
Table 96. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 97. Cooper Medical, Inc. Latest Developments
Table 98. Thermo Fisher Scientific Inc. Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 99. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 100. Thermo Fisher Scientific Inc. Main Business
Table 101. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 102. Thermo Fisher Scientific Inc. Latest Developments
Table 103. LabCorp Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 104. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 105. LabCorp Main Business
Table 106. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Revenue and Gross Margin (2018-2020E)
Table 107. LabCorp Latest Developments
Table 108. Reproductive Genetic Innovations Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
Table 109. CombiMatrix Details, Company Total Revenue (in $ million), Head Office, Pre-Implantation Genetic Diagnosis (PGD) Major Market Areas and Its Competitors
List of Figures
Figure 1. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
Figure 5. Global Chromosomal Abnormalities Market Size Growth Rate
Figure 6. Global X-linked Diseases Market Size Growth Rate
Figure 7. Global Freeze Embryo Testing Market Size Growth Rate
Figure 8. Global Aneuploidy Screening Market Size Growth Rate
Figure 9. Global HLA Market Size Growth Rate
Figure 10. Global Others Market Size Growth Rate
Figure 11. Pre-Implantation Genetic Diagnosis (PGD) in Stem Cell Therapy
Figure 12. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Stem Cell Therapy (2015-2020) ($ Millions)
Figure 13. Pre-Implantation Genetic Diagnosis (PGD) in IVF Prognosis
Figure 14. Global Pre-Implantation Genetic Diagnosis (PGD) Market: IVF Prognosis (2015-2020) ($ Millions)
Figure 15. Pre-Implantation Genetic Diagnosis (PGD) in Late-Onset Genetic Disorders
Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Late-Onset Genetic Disorders (2015-2020) ($ Millions)
Figure 17. Global Late-Onset Genetic Disorders YoY Growth ($ Millions)
Figure 18. Pre-Implantation Genetic Diagnosis (PGD) in Inherited Genetic Disease
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Inherited Genetic Disease (2015-2020) ($ Millions)
Figure 20. Global Inherited Genetic Disease YoY Growth ($ Millions)
Figure 21. Pre-Implantation Genetic Diagnosis (PGD) in Others
Figure 22. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Others (2015-2020) ($ Millions)
Figure 23. Global Others YoY Growth ($ Millions)
Figure 24. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2019
Figure 25. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Regions 2015-2020
Figure 26. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size 2015-2020 ($ Millions)
Figure 27. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size 2015-2020 ($ Millions)
Figure 28. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size 2015-2020 ($ Millions)
Figure 29. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2015-2020 ($ Millions)
Figure 30. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries in 2019
Figure 31. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2019
Figure 32. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2019
Figure 33. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 34. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 35. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 36. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Regions in 2019
Figure 37. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2019
Figure 38. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2019
Figure 39. China Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 40. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 42. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 43. India Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 44. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries in 2019
Figure 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2019
Figure 47. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2019
Figure 48. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 49. France Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 50. UK Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 51. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 52. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 53. Spain Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 54. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Countries in 2019
Figure 55. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2019
Figure 56. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2019
Figure 57. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 58. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 59. Israel Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 60. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 61. GCC Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 62. Global Pre-Implantation Genetic Diagnosis (PGD) arket Size Forecast (2021-2025) ($ Millions)
Figure 63. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 64. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 65. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 66. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 67. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 68. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 69. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 70. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 71. China Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 72. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 73. Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 74. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 75. India Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 76. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 77. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 78. France Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 79. UK Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 80. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 81. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 82. Spain Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 83. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 84. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 85. Israel Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 86. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Figure 87. GCC Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets